Related Experiment Video
Updated: May 24, 2026

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
Published on: March 2, 2016
The PI3K/Akt pathway contributes to arenavirus budding
Shuzo Urata1, Nhi Ngo, Juan Carlos de la Torre
1Department of Immunology and Microbial Science IMM-6, The Scripps Research Institute, La Jolla, California, USA.
Abstract:
Several arenaviruses, chiefly Lassa virus (LASV), cause hemorrhagic fever (HF) disease in humans and pose a significant public health concern in regions where they are endemic. On the other hand, evidence indicates that the globally distributed prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) is a neglected human pathogen. The phosphatidylinositol 3-kinase (PI3K)/Akt pathway participates in many cellular processes, including cell survival and differentiation, and also has been shown to play important roles in different steps of the life cycles of a variety of viruses. Here we report that the inhibition of the PI3K/Akt pathway inhibited budding and to a lesser extent RNA synthesis, but not cell entry, of LCMV. Accordingly, BEZ-235, a PI3K inhibitor currently in cancer clinical trials, inhibited LCMV multiplication in cultured cells. These findings, together with those previously reported for Junin virus (JUNV), indicate that targeting the PI3K/Akt pathway could represent a novel antiviral strategy to combat human-pathogenic arenaviruses.
Insights
Targeting the PI3K/Akt pathway inhibits lymphocytic choriomeningitis virus (LCMV) replication by affecting viral budding and RNA synthesis. This suggests a novel antiviral strategy for arenavirus infections.
Area of Science:
- Virology
- Molecular Biology
- Cellular Biology
Background:
- Arenaviruses, including Lassa virus (LASV), cause significant human hemorrhagic fever (HF).
- Lymphocytic choriomeningitis virus (LCMV), a globally distributed arenavirus, is a neglected human pathogen.
- The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is crucial for cellular processes and viral replication.
Purpose of the Study:
- To investigate the role of the PI3K/Akt pathway in the life cycle of LCMV.
- To evaluate the potential of PI3K/Akt pathway inhibition as an antiviral strategy against LCMV.
Main Methods:
- Inhibition of the PI3K/Akt pathway in cultured cells infected with LCMV.
- Assessment of viral RNA synthesis and budding upon pathway inhibition.
- Treatment of LCMV-infected cells with BEZ-235, a PI3K inhibitor.
Main Results:
- Inhibition of the PI3K/Akt pathway significantly reduced LCMV budding and, to a lesser extent, RNA synthesis.
- Cell entry of LCMV was not affected by PI3K/Akt pathway inhibition.
- The PI3K inhibitor BEZ-235 effectively inhibited LCMV multiplication in cell culture.
Conclusions:
- The PI3K/Akt pathway is essential for LCMV replication, particularly for viral budding.
- Targeting the PI3K/Akt pathway represents a promising antiviral approach for human-pathogenic arenaviruses, including LCMV and Junin virus (JUNV).
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
piRNA - Piwi-interacting RNAs
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway
Viruses of Archaea
Pinching-off of Coated Vesicles

